Luke J Kubiatowicz (Luke Kubiatowicz)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

End Stage Renal Disease

Circulating Tumor Cells

Gold Nanoparticles

Top Venues

Exploration (Beijing, China)

This page only lists publications with an associated author ORCID identifier.

Publications

Rodolfo Mundaca-Uribe, Maya Holay, Amal Abbas, Nelly Askarinam, Janna Sofia Sage-Sepulveda, Luke J Kubiatowicz, Ronnie H Fang, Liangfang Zhang, Joseph Wang
A Microstirring Oral Pill for Improving the Glucose-Lowering Effect of Metformin. ACS nano 17 (10) (2023)
Rodolfo Mundaca-Uribe, Maya Holay, Amal Abbas, Nelly Askarinam, Janna Sofia Sage-Sepulveda, Luke J Kubiatowicz, Ronnie H Fang, Liangfang Zhang, Joseph Wang
A Microstirring Oral Pill for Improving the Glucose-Lowering Effect of Metformin. ACS nano (2023)
Tae Hee Lee, Piper A Rawding, Jiyoon Bu, Sung Hee Hyun, Woo Sun Rou, Hongjae Jeon, Seokhyun Kim, Byungseok Lee, Luke J Kubiatowicz, Dawon Kim, Seungpyo Hong, Hyuk Soo Eun
Machine-Learning-Based Clinical Biomarker Using Cell-Free DNA for Hepatocellular Carcinoma (HCC). Cancers 14 (9) (2022)
Luke J Kubiatowicz, Animesh Mohapatra, Nishta Krishnan, Ronnie H Fang, Liangfang Zhang
mRNA nanomedicine: Design and recent applications. Exploration (Beijing, China) (2022)